Aberrant RNA Splicing and Therapeutic Opportunities in Cancers.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer science"
DOI: 10.1111/cas.15213
Abstract: There has been accumulating evidence that RNA splicing is frequently dysregulated in a variety of cancers and that hotspot mutations affecting key splicing factors, SF3B1, SRSF2 and U2AF1, are commonly enriched across cancers, strongly suggesting… read more here.
Keywords: opportunities cancers; aberrant rna; therapeutic opportunities; rna splicing ... See more keywords